Cell-based strategies for IVD repair: clinical progress and translational obstacles

ALA Binch, JC Fitzgerald, EA Growney… - Nature Reviews …, 2021 - nature.com
Intervertebral disc (IVD) degeneration is a major cause of low back pain, a prevalent and
chronic condition that has a striking effect on quality of life. Currently, no approved …

Non-specific low back pain

C Maher, M Underwood, R Buchbinder - The Lancet, 2017 - thelancet.com
Non-specific low back pain affects people of all ages and is a leading contributor to disease
burden worldwide. Management guidelines endorse triage to identify the rare cases of low …

[HTML][HTML] CDC clinical practice guideline for prescribing opioids for pain—United States, 2022

D Dowell - MMWR. Recommendations and reports, 2022 - cdc.gov
This guideline provides recommendations for clinicians providing pain care, including those
prescribing opioids, for outpatients aged≥ 18 years. It updates the CDC Guideline for …

[HTML][HTML] Injectable exosome-functionalized extracellular matrix hydrogel for metabolism balance and pyroptosis regulation in intervertebral disc degeneration

H Xing, Z Zhang, Q Mao, C Wang, Y Zhou… - Journal of …, 2021 - Springer
Exosome therapy is a promising therapeutic approach for intervertebral disc degeneration
(IVDD) and achieves its therapeutic effects by regulating metabolic disorders, the …

Cognitive functional therapy with or without movement sensor biofeedback versus usual care for chronic, disabling low back pain (RESTORE): a randomised …

P Kent, T Haines, P O'Sullivan, A Smith, A Campbell… - The Lancet, 2023 - thelancet.com
Background Low back pain is the leading cause of years lived with disability globally, but
most interventions have only short-lasting, small to moderate effects. Cognitive functional …

[HTML][HTML] Prognostic factors for pain chronicity in low back pain: a systematic review

LK Nieminen, LM Pyysalo, MJ Kankaanpää - Pain reports, 2021 - journals.lww.com
Low back pain is the leading cause for years lived in disability. Most people with acute low
back pain improve rapidly, but 4% to 25% of patients become chronic. Since the previous …

The cost of work-related stress to society: A systematic review.

J Hassard, KRH Teoh, G Visockaite… - … of occupational health …, 2018 - psycnet.apa.org
A systematic review of the available evidence examining the cost of work-related stress
(WRS) would yield important insights into the magnitude of this social phenomenon. The …

Responsible, safe, and effective prescription of opioids for chronic non-cancer pain: American Society of Interventional Pain Physicians (ASIPP) guidelines

L Manchikanti, AM Kaye, NN Knezevic… - Pain …, 2017 - scholarlycommons.pacific.edu
Background: Opioid use, abuse, and adverse consequences, including death, have
escalated at an alarming rate since the 1990s. In an attempt to control opioid abuse …

The burden of neurological disease in the United States: A summary report and call to action.

CL Gooch, E Pracht, AR Borenstein - Annals of neurology, 2017 - europepmc.org
The burden of neurological disease in the United States: A summary report and call to action. -
Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About …

Economic impact of musculoskeletal disorders (MSDs) on work in Europe

S Bevan - Best Practice & Research Clinical Rheumatology, 2015 - Elsevier
Musculoskeletal disorders (MSDs) are the leading cause of work disability, sickness
absence from work,'presenteeism'and loss of productivity across all the European Union …